Medicare’s $2,100 Drug Quietly Reshapes Prescription Costs for Investors
Medicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
An index aggregates price movement to summarize market direction, helping traders and investors gauge momentum and risk.
28,327 articlesMedicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
Actor Zac Efron is pursuing an off-grid hemp home project on a remote plot in Australia, signaling a shift toward sus...
New data covering about 88 million employees shows worker engagement at a decade-low, with managerial practices ident...
JPMORGAN Global Research says the AI-related capital spend is not a fleeting hype cycle but a profitable buildout. Th...
A prominent on-chain researcher raised alarms about AscendEX withdrawal processing, with users reporting multi-day de...
A Jersey Republican is set to reappear in Congress after nearly four months away, citing an unspecified medical condi...
The housing story of 2026 isn’t about a vanished dream. It’s about where the American Dream still thrives—where build...
Apple advances a leadership shift, naming hardware chief John Ternus as the next CEO, effective Sept. 1, 2026. Tim Co...
AI’s power needs are lifting uranium miners into mainstream focus, aided by the URA ETF as nuclear energy gains renew...
Rising gray divorces are pushing older homeowners to consider reverse mortgages as a financial lever. A new wave of s...
AI is redefining the CMO role, pushing marketing leaders toward broader corporate leadership. In 2026, budgets, gover...
Perplexity’s decision to base its AI tooling on Nvidia’s Vera CPUs over AMD’s x86 chips signals a major shift in the ...